Klea Holding Inc. | Small-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2018

Income Metrics

EPS (Diluted) €0.00

Balance Sheet Metrics

Total Assets 37.8M
Total Liabilities 10.0M
Shareholders Equity 27.8M
Debt to Equity 0.36

Cash Flow Metrics

Revenue & Profitability Trend

Klea Holding Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i17.3M13.7M14.4M7.2M19.0M
Cost of Goods Sold i9.0M7.4M11.2M7.9M22.7M
Gross Profit i8.3M6.3M3.2M-715.0K-3.8M
Gross Margin % i47.8%46.0%22.2%-10.0%-19.8%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-----
Other Operating Expenses i-23.0K801.0K832.0K-786.0K
Total Operating Expenses i023.0K801.0K832.0K-786.0K
Operating Income i1.9M952.0K-3.9M-3.7M-6.6M
Operating Margin % i11.3%6.9%-27.1%-51.3%-34.8%
Non-Operating Items
Interest Income i275.0K112.0K4.0K12.0K-
Interest Expense i758.0K1.2M182.0K618.0K382.0K
Other Non-Operating Income-----
Pre-tax Income i1.5M1.5M-5.1M-4.2M-5.2M
Income Tax i267.0K-37.0K113.0K142.0K-164.0K
Effective Tax Rate % i17.8%-2.4%0.0%0.0%0.0%
Net Income i1.4M902.0K-5.3M-4.5M-5.2M
Net Margin % i8.1%6.6%-36.5%-62.1%-27.1%
Key Metrics
EBITDA i3.8M4.2M-1.2M-2.9M-6.7M
EPS (Basic) i-€0.00€-0.02€-0.03€-0.20
EPS (Diluted) i-€0.00€-0.02€-0.03€-0.20
Basic Shares Outstanding i-29435641926385000013808738925382874
Diluted Shares Outstanding i-29435641926385000013808738925382874

Income Statement Trend

Klea Holding Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i3.3M3.0M2.4M6.6M779.0K
Short-term Investments i---7.0K31.0K
Accounts Receivable i1.7M1.2M1.8M4.6M252.0K
Inventory i19.0K0658.0K1.4M1.3M
Other Current Assets2.0K-410.0K203.0K330.0K
Total Current Assets i7.1M5.3M7.0M16.0M5.1M
Non-Current Assets
Property, Plant & Equipment i8.2M7.3M13.0M8.5M1.0M
Goodwill i49.7M49.5M38.3M44.1M541.0K
Intangible Assets i539.0K356.0K374.0K90.0K97.0K
Long-term Investments-----
Other Non-Current Assets-1.0K-1.0K-101.0K1.0K
Total Non-Current Assets i30.7M31.3M29.1M28.1M832.0K
Total Assets i37.8M36.6M36.1M44.1M5.9M
Liabilities
Current Liabilities
Accounts Payable i1.6M2.1M3.0M17.3M5.2M
Short-term Debt i97.0K287.0K127.0K5.0M2.0K
Current Portion of Long-term Debt-----
Other Current Liabilities--310.0K13.0M69.0K
Total Current Liabilities i3.5M3.4M5.5M24.2M8.8M
Non-Current Liabilities
Long-term Debt i5.8M7.6M5.5M013.0K
Deferred Tax Liabilities i-----
Other Non-Current Liabilities--1.0K-1.0K1.2M406.0K
Total Non-Current Liabilities i6.5M8.5M6.3M5.8M1.5M
Total Liabilities i10.0M11.8M11.8M30.0M10.3M
Equity
Common Stock i3.1M2.9M2.9M1.4M20.3M
Retained Earnings i1.4M902.0K-5.3M-4.5M-36.7M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i27.8M24.7M24.3M14.1M-4.4M
Key Metrics
Total Debt i5.9M7.9M5.6M5.0M15.0K
Working Capital i3.6M1.9M1.5M-8.2M-3.7M

Balance Sheet Composition

Klea Holding Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i1.2M902.0K-5.3M-4.5M-5.2M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i00000
Operating Cash Flow i769.0K-1.3M-5.3M-4.5M-5.2M
Investing Activities
Capital Expenditures i-626.0K-1.8M-5.5M-171.0K3.1M
Acquisitions i-----
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-626.0K-1.6M-17.5M-15.0M3.1M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i2.0M2.4M12.2M26.0M1.6M
Debt Repayment i-3.9M-1.3M-650.0K-713.0K-1.6M
Financing Cash Flow i-199.0K1.0M14.8M27.2M0
Free Cash Flow i166.0K-1.5M-7.3M-6.7M-11.1M
Net Change in Cash i-56.0K-1.8M-8.0M7.7M-2.1M

Cash Flow Trend

Klea Holding Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 17.87
Price to Book 2.27
Price to Sales 3.74

Profitability Ratios

Profit Margin 8.14%
Operating Margin 14.55%
Return on Equity 5.35%
Return on Assets 3.27%

Financial Health

Current Ratio 1.41
Debt to Equity 21.13
Beta -1.12

Per Share Data

EPS (TTM) €0.00
Book Value per Share €0.09
Revenue per Share €0.06

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
alklh64.5M17.872.275.35%8.14%21.13
bioMérieux S.A 15.0B35.003.5710.68%10.86%11.65
Eurofins Scientific 12.2B30.013.538.68%6.05%88.06
Eurofins Cerep SAS 92.8M12.97-10.49%17.67%0.46
Predilife S.A 12.3M---4,653.75%97.76%-1.16
Lumibird S.A 400.6M70.002.022.91%2.71%81.34

Financial data is updated regularly. All figures are in the company's reporting currency.